Agree. If we nail the neurodegenerative size, the payout will be large enough that I certainly won't give a hoot about covid, canine cancer etc. I'd rather they focus all efforts on getting one single use nailed and getting a multi billion dollar buyout (if they believe this is a strong chance), rather than spreading efforts, causing more complexity, more delays, less focused efforts.
Get this to $2+ plus and I can forget we missed the covid boat, and that there was never any canine interest.
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial, page-917
-
- There are more pages in this discussion • 62 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
18.5¢ |
Change
0.005(2.78%) |
Mkt cap ! $89.95M | |||
| Open | High | Low | Value | Volume |
| 18.5¢ | 19.0¢ | 18.5¢ | $111.6K | 601.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 169572 | 18.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.0¢ | 613756 | 10 |
View Market Depth
| Last trade - 15.46pm 30/08/2024 (20 minute delay) ? |
| PAA (ASX) Chart |